biliary tract, Gastrointestinal tract, or pancreatic cancers with homozygous methylthioadenosine phosphorylase (MTAP)-deletion
Conditions
Interventions
None listed
Sponsors
Amgen Inc.
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Countries
Belgium, Denmark, France, Germany, Greece, Italy, Netherlands, Spain
Outcome results
None listed